Mettler-Toledo International’s (MTD) Neutral Rating Reaffirmed at Bank of America

Bank of America reiterated their neutral rating on shares of Mettler-Toledo International (NYSE:MTD) in a research report sent to investors on Tuesday morning, Briefing.com Automated Import reports. Bank of America currently has a $755.00 target price on the medical instruments supplier’s stock, up from their previous target price of $725.00.

A number of other brokerages have also issued reports on MTD. Zacks Investment Research upgraded Mettler-Toledo International from a hold rating to a buy rating and set a $742.00 target price on the stock in a research report on Tuesday, February 12th. ValuEngine upgraded Mettler-Toledo International from a hold rating to a buy rating in a research report on Thursday, January 24th. Finally, Evercore ISI lowered Mettler-Toledo International from an in-line rating to an underperform rating in a research report on Thursday, January 3rd. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of $650.67.

Shares of NYSE:MTD opened at $732.17 on Tuesday. Mettler-Toledo International has a 1 year low of $500.74 and a 1 year high of $750.00. The company has a market cap of $18.49 billion, a PE ratio of 36.03, a price-to-earnings-growth ratio of 2.64 and a beta of 1.35. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.06 and a current ratio of 1.42.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 7th. The medical instruments supplier reported $6.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.11. Mettler-Toledo International had a return on equity of 94.57% and a net margin of 17.46%. The firm had revenue of $817.92 million for the quarter, compared to analyst estimates of $807.58 million. During the same quarter last year, the firm posted $5.97 EPS. The business’s revenue was up 5.1% on a year-over-year basis. Sell-side analysts expect that Mettler-Toledo International will post 22.66 EPS for the current fiscal year.

In related news, Director Robert F. Spoerry sold 23,175 shares of the stock in a transaction on Tuesday, February 12th. The stock was sold at an average price of $665.14, for a total value of $15,414,619.50. Following the completion of the transaction, the director now directly owns 7,894 shares of the company’s stock, valued at approximately $5,250,615.16. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 250 shares of the stock in a transaction on Monday, February 11th. The shares were sold at an average price of $664.50, for a total value of $166,125.00. Following the completion of the transaction, the insider now directly owns 404 shares of the company’s stock, valued at $268,458. The disclosure for this sale can be found here. Over the last three months, insiders sold 150,995 shares of company stock valued at $100,997,450. 3.50% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Nordea Investment Management AB increased its stake in shares of Mettler-Toledo International by 65.0% in the 4th quarter. Nordea Investment Management AB now owns 37,599 shares of the medical instruments supplier’s stock worth $21,266,000 after acquiring an additional 14,805 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Mettler-Toledo International by 2.2% in the 3rd quarter. Legal & General Group Plc now owns 122,899 shares of the medical instruments supplier’s stock worth $74,842,000 after acquiring an additional 2,701 shares during the last quarter. Macquarie Group Ltd. increased its stake in shares of Mettler-Toledo International by 28.6% in the 3rd quarter. Macquarie Group Ltd. now owns 900 shares of the medical instruments supplier’s stock worth $548,000 after acquiring an additional 200 shares during the last quarter. Fiera Capital Corp increased its stake in shares of Mettler-Toledo International by 4.2% in the 4th quarter. Fiera Capital Corp now owns 704,726 shares of the medical instruments supplier’s stock worth $398,579,000 after acquiring an additional 28,271 shares during the last quarter. Finally, Wetherby Asset Management Inc. increased its stake in shares of Mettler-Toledo International by 2.8% in the 4th quarter. Wetherby Asset Management Inc. now owns 891 shares of the medical instruments supplier’s stock worth $504,000 after acquiring an additional 24 shares during the last quarter. 95.69% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

Further Reading: What is the 52-week high/low?

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.